The pathogenesis of CML is based on the expression of P210 BCR-ABL protein, encoded by the Breakpoint Cluster Region-Abelson (BCR-ABL) gene. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.